Global Lung Cancer Liquid Biopsy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Lung Cancer Liquid Biopsy market size was valued at USD 438 million in 2023 and is forecast to a readjusted size of USD 1056.2 million by 2030 with a CAGR of 13.4% during review period.
Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.
CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.
The Global Info Research report includes an overview of the development of the Lung Cancer Liquid Biopsy industry chain, the market status of Clinics (CTCs, CtDNA), Hospitals (CTCs, CtDNA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Lung Cancer Liquid Biopsy.
Regionally, the report analyzes the Lung Cancer Liquid Biopsy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Lung Cancer Liquid Biopsy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Lung Cancer Liquid Biopsy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Lung Cancer Liquid Biopsy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CTCs, CtDNA).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Lung Cancer Liquid Biopsy market.
Regional Analysis: The report involves examining the Lung Cancer Liquid Biopsy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Lung Cancer Liquid Biopsy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Lung Cancer Liquid Biopsy:
Company Analysis: Report covers individual Lung Cancer Liquid Biopsy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Lung Cancer Liquid Biopsy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinics, Hospitals).
Technology Analysis: Report covers specific technologies relevant to Lung Cancer Liquid Biopsy. It assesses the current state, advancements, and potential future developments in Lung Cancer Liquid Biopsy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Lung Cancer Liquid Biopsy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Lung Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Lung Cancer Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Cancer Liquid Biopsy, with revenue, gross margin and global market share of Lung Cancer Liquid Biopsy from 2019 to 2024.
Chapter 3, the Lung Cancer Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Lung Cancer Liquid Biopsy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Liquid Biopsy.
Chapter 13, to describe Lung Cancer Liquid Biopsy research findings and conclusion.
Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.
CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.
The Global Info Research report includes an overview of the development of the Lung Cancer Liquid Biopsy industry chain, the market status of Clinics (CTCs, CtDNA), Hospitals (CTCs, CtDNA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Lung Cancer Liquid Biopsy.
Regionally, the report analyzes the Lung Cancer Liquid Biopsy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Lung Cancer Liquid Biopsy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Lung Cancer Liquid Biopsy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Lung Cancer Liquid Biopsy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CTCs, CtDNA).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Lung Cancer Liquid Biopsy market.
Regional Analysis: The report involves examining the Lung Cancer Liquid Biopsy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Lung Cancer Liquid Biopsy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Lung Cancer Liquid Biopsy:
Company Analysis: Report covers individual Lung Cancer Liquid Biopsy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Lung Cancer Liquid Biopsy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinics, Hospitals).
Technology Analysis: Report covers specific technologies relevant to Lung Cancer Liquid Biopsy. It assesses the current state, advancements, and potential future developments in Lung Cancer Liquid Biopsy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Lung Cancer Liquid Biopsy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Lung Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- CTCs
- CtDNA
- Exosomes And RNA
- Others
- Clinics
- Hospitals
- Physicians' Office Laboratories
- Biocept
- Exosome Diagnostics
- F. Hoffmann-La Roche
- Qiagen
- Accuragen
- Agena Bioscience
- Bard1
- Bgi
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Lung Cancer Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Cancer Liquid Biopsy, with revenue, gross margin and global market share of Lung Cancer Liquid Biopsy from 2019 to 2024.
Chapter 3, the Lung Cancer Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Lung Cancer Liquid Biopsy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Cancer Liquid Biopsy.
Chapter 13, to describe Lung Cancer Liquid Biopsy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Lung Cancer Liquid Biopsy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lung Cancer Liquid Biopsy by Type
1.3.1 Overview: Global Lung Cancer Liquid Biopsy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Lung Cancer Liquid Biopsy Consumption Value Market Share by Type in 2023
1.3.3 CTCs
1.3.4 CtDNA
1.3.5 Exosomes And RNA
1.3.6 Others
1.4 Global Lung Cancer Liquid Biopsy Market by Application
1.4.1 Overview: Global Lung Cancer Liquid Biopsy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinics
1.4.3 Hospitals
1.4.4 Physicians' Office Laboratories
1.5 Global Lung Cancer Liquid Biopsy Market Size & Forecast
1.6 Global Lung Cancer Liquid Biopsy Market Size and Forecast by Region
1.6.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Lung Cancer Liquid Biopsy Market Size by Region, (2019-2030)
1.6.3 North America Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.4 Europe Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.6 South America Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Biocept
2.1.1 Biocept Details
2.1.2 Biocept Major Business
2.1.3 Biocept Lung Cancer Liquid Biopsy Product and Solutions
2.1.4 Biocept Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Biocept Recent Developments and Future Plans
2.2 Exosome Diagnostics
2.2.1 Exosome Diagnostics Details
2.2.2 Exosome Diagnostics Major Business
2.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Product and Solutions
2.2.4 Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Exosome Diagnostics Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business
2.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product and Solutions
2.3.4 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen Lung Cancer Liquid Biopsy Product and Solutions
2.4.4 Qiagen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Qiagen Recent Developments and Future Plans
2.5 Accuragen
2.5.1 Accuragen Details
2.5.2 Accuragen Major Business
2.5.3 Accuragen Lung Cancer Liquid Biopsy Product and Solutions
2.5.4 Accuragen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Accuragen Recent Developments and Future Plans
2.6 Agena Bioscience
2.6.1 Agena Bioscience Details
2.6.2 Agena Bioscience Major Business
2.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Product and Solutions
2.6.4 Agena Bioscience Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Agena Bioscience Recent Developments and Future Plans
2.7 Bard1
2.7.1 Bard1 Details
2.7.2 Bard1 Major Business
2.7.3 Bard1 Lung Cancer Liquid Biopsy Product and Solutions
2.7.4 Bard1 Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bard1 Recent Developments and Future Plans
2.8 Bgi
2.8.1 Bgi Details
2.8.2 Bgi Major Business
2.8.3 Bgi Lung Cancer Liquid Biopsy Product and Solutions
2.8.4 Bgi Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bgi Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lung Cancer Liquid Biopsy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Lung Cancer Liquid Biopsy by Company Revenue
3.2.2 Top 3 Lung Cancer Liquid Biopsy Players Market Share in 2023
3.2.3 Top 6 Lung Cancer Liquid Biopsy Players Market Share in 2023
3.3 Lung Cancer Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Lung Cancer Liquid Biopsy Market: Region Footprint
3.3.2 Lung Cancer Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Lung Cancer Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lung Cancer Liquid Biopsy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Lung Cancer Liquid Biopsy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lung Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2024)
5.2 Global Lung Cancer Liquid Biopsy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
6.2 North America Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
6.3 North America Lung Cancer Liquid Biopsy Market Size by Country
6.3.1 North America Lung Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
6.3.2 United States Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
6.3.3 Canada Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
6.3.4 Mexico Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
7.2 Europe Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
7.3 Europe Lung Cancer Liquid Biopsy Market Size by Country
7.3.1 Europe Lung Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
7.3.2 Germany Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.3 France Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.5 Russia Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.6 Italy Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Liquid Biopsy Consumption Value by Region (2019-2030)
8.3.2 China Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.3 Japan Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.4 South Korea Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.5 India Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.7 Australia Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
9.2 South America Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
9.3 South America Lung Cancer Liquid Biopsy Market Size by Country
9.3.1 South America Lung Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
9.3.2 Brazil Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
9.3.3 Argentina Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
10.3.2 Turkey Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10.3.4 UAE Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Lung Cancer Liquid Biopsy Market Drivers
11.2 Lung Cancer Liquid Biopsy Market Restraints
11.3 Lung Cancer Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lung Cancer Liquid Biopsy Industry Chain
12.2 Lung Cancer Liquid Biopsy Upstream Analysis
12.3 Lung Cancer Liquid Biopsy Midstream Analysis
12.4 Lung Cancer Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Lung Cancer Liquid Biopsy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lung Cancer Liquid Biopsy by Type
1.3.1 Overview: Global Lung Cancer Liquid Biopsy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Lung Cancer Liquid Biopsy Consumption Value Market Share by Type in 2023
1.3.3 CTCs
1.3.4 CtDNA
1.3.5 Exosomes And RNA
1.3.6 Others
1.4 Global Lung Cancer Liquid Biopsy Market by Application
1.4.1 Overview: Global Lung Cancer Liquid Biopsy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinics
1.4.3 Hospitals
1.4.4 Physicians' Office Laboratories
1.5 Global Lung Cancer Liquid Biopsy Market Size & Forecast
1.6 Global Lung Cancer Liquid Biopsy Market Size and Forecast by Region
1.6.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Lung Cancer Liquid Biopsy Market Size by Region, (2019-2030)
1.6.3 North America Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.4 Europe Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.6 South America Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Lung Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Biocept
2.1.1 Biocept Details
2.1.2 Biocept Major Business
2.1.3 Biocept Lung Cancer Liquid Biopsy Product and Solutions
2.1.4 Biocept Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Biocept Recent Developments and Future Plans
2.2 Exosome Diagnostics
2.2.1 Exosome Diagnostics Details
2.2.2 Exosome Diagnostics Major Business
2.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Product and Solutions
2.2.4 Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Exosome Diagnostics Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business
2.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product and Solutions
2.3.4 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen Lung Cancer Liquid Biopsy Product and Solutions
2.4.4 Qiagen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Qiagen Recent Developments and Future Plans
2.5 Accuragen
2.5.1 Accuragen Details
2.5.2 Accuragen Major Business
2.5.3 Accuragen Lung Cancer Liquid Biopsy Product and Solutions
2.5.4 Accuragen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Accuragen Recent Developments and Future Plans
2.6 Agena Bioscience
2.6.1 Agena Bioscience Details
2.6.2 Agena Bioscience Major Business
2.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Product and Solutions
2.6.4 Agena Bioscience Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Agena Bioscience Recent Developments and Future Plans
2.7 Bard1
2.7.1 Bard1 Details
2.7.2 Bard1 Major Business
2.7.3 Bard1 Lung Cancer Liquid Biopsy Product and Solutions
2.7.4 Bard1 Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bard1 Recent Developments and Future Plans
2.8 Bgi
2.8.1 Bgi Details
2.8.2 Bgi Major Business
2.8.3 Bgi Lung Cancer Liquid Biopsy Product and Solutions
2.8.4 Bgi Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bgi Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lung Cancer Liquid Biopsy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Lung Cancer Liquid Biopsy by Company Revenue
3.2.2 Top 3 Lung Cancer Liquid Biopsy Players Market Share in 2023
3.2.3 Top 6 Lung Cancer Liquid Biopsy Players Market Share in 2023
3.3 Lung Cancer Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Lung Cancer Liquid Biopsy Market: Region Footprint
3.3.2 Lung Cancer Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Lung Cancer Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lung Cancer Liquid Biopsy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Lung Cancer Liquid Biopsy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lung Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2024)
5.2 Global Lung Cancer Liquid Biopsy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
6.2 North America Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
6.3 North America Lung Cancer Liquid Biopsy Market Size by Country
6.3.1 North America Lung Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
6.3.2 United States Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
6.3.3 Canada Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
6.3.4 Mexico Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
7.2 Europe Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
7.3 Europe Lung Cancer Liquid Biopsy Market Size by Country
7.3.1 Europe Lung Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
7.3.2 Germany Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.3 France Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.5 Russia Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.6 Italy Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Lung Cancer Liquid Biopsy Consumption Value by Region (2019-2030)
8.3.2 China Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.3 Japan Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.4 South Korea Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.5 India Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.7 Australia Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
9.2 South America Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
9.3 South America Lung Cancer Liquid Biopsy Market Size by Country
9.3.1 South America Lung Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
9.3.2 Brazil Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
9.3.3 Argentina Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lung Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Lung Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Lung Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
10.3.2 Turkey Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10.3.4 UAE Lung Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Lung Cancer Liquid Biopsy Market Drivers
11.2 Lung Cancer Liquid Biopsy Market Restraints
11.3 Lung Cancer Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lung Cancer Liquid Biopsy Industry Chain
12.2 Lung Cancer Liquid Biopsy Upstream Analysis
12.3 Lung Cancer Liquid Biopsy Midstream Analysis
12.4 Lung Cancer Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
